{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:05:07Z","timestamp":1770149107769,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32477-x","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:17:39Z","timestamp":1765595859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum prolactin level in male type 2 diabetes mellitus patients at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2024"],"prefix":"10.1038","volume":"16","author":[{"given":"Arega","family":"Zenaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Chane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getnet","family":"Fetene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sintayehu","family":"Admas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigusie","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitkie","family":"Tigabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belete","family":"Biadgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abebaw","family":"Worede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"1","key":"32477_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.autrev.2009.02.031","volume":"9","author":"P Cejkova","year":"2009","unstructured":"Cejkova, P., Fojtikova, M. & Cerna, M. Immunomodulatory role of prolactin in diabetes development. Autoimmun. Rev. 9 (1), 23\u201327 (2009).","journal-title":"Autoimmun. rev."},{"issue":"4","key":"32477_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","volume":"9","author":"T Brandebourg","year":"2007","unstructured":"Brandebourg, T., Hugo, E. & Ben-Jonathan, N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes. Metabol.. 9 (4), 464\u2013476 (2007).","journal-title":"Diabetes Obes. Metabolism"},{"issue":"3","key":"32477_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","volume":"17","author":"N Ben-Jonathan","year":"2006","unstructured":"Ben-Jonathan, N., Hugo, E. R., Brandebourg, T. D. & LaPensee, C. R. Focus on prolactin as a metabolic hormone. Trends Endocrinol. Metabol.. 17 (3), 110\u2013116 (2006).","journal-title":"Trends Endocrinol. Metabolism"},{"issue":"35","key":"32477_CR4","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.1523\/JNEUROSCI.1471-16.2016","volume":"36","author":"RS Brown","year":"2016","unstructured":"Brown, R. S. et al. Conditional deletion of the prolactin receptor reveals functional subpopulations of dopamine neurons in the arcuate nucleus of the hypothalamus. J. Neurosci. 36 (35), 9173\u20139185 (2016).","journal-title":"J. Neurosci."},{"issue":"23","key":"32477_CR5","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1523\/JNEUROSCI.0129-12.2012","volume":"32","author":"DJ Lyons","year":"2012","unstructured":"Lyons, D. J., Hellysaz, A. & Broberger, C. Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: novel feedback control mechanisms in the lactotrophic axis. J. Neurosci. 32 (23), 8074\u20138083 (2012).","journal-title":"J. Neurosci."},{"issue":"10","key":"32477_CR6","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.4415-12.2013","volume":"33","author":"N Romano","year":"2013","unstructured":"Romano, N. et al. Plasticity of hypothalamic dopamine neurons during lactation results in dissociation of electrical activity and release. J. Neurosci. 33 (10), 4424\u20134433 (2013).","journal-title":"J. Neurosci."},{"key":"32477_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","volume":"14","author":"K Berinder","year":"2011","unstructured":"Berinder, K., Nystr\u00f6m, T., H\u00f6ybye, C., Hall, K. & Hulting, A-L. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 14, 199\u2013207 (2011).","journal-title":"Pituitary"},{"issue":"9","key":"32477_CR8","first-page":"1904","volume":"7","author":"HK VS","year":"2013","unstructured":"VS, H. K. et al. Bromocriptine, a dopamine (d2) receptor Agonist, used alone and in combination with glipizide in Sub\u2013Therapeutic doses to ameliorate hyperglycaemia. J. Clin. Diagn. Res.  JCDR. 7 (9), 1904 (2013).","journal-title":"J. Clin. Diagn. Research: JCDR"},{"issue":"10","key":"32477_CR9","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1210\/en.2006-0487","volume":"147","author":"CR LaPensee","year":"2006","unstructured":"LaPensee, C. R. et al. The prolactin-deficient mouse has an unaltered metabolic phenotype. Endocrinology 147 (10), 4638\u20134645 (2006).","journal-title":"Endocrinology"},{"key":"32477_CR10","unstructured":"Coulter, B. & Instructions For Use, P. ; cited. [updated https:\/\/www.beckmancoulter.com\/download\/phxC85674E-EN_US (2025)."},{"issue":"1","key":"32477_CR11","first-page":"9253083","volume":"2018","author":"S Levine","year":"2018","unstructured":"Levine, S. & Muneyyirci-Delale, O. Stress-induced hyperprolactinemia: pathophysiology and clinical approach. Obstet. Gynecol. Int. 2018 (1), 9253083 (2018).","journal-title":"Obstet. Gynecol. Int."},{"key":"32477_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s13277-013-0660-z","volume":"34","author":"X-B Jiang","year":"2013","unstructured":"Jiang, X-B. et al. BMI, Apolipoprotein B\/apolipoprotein AI ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort. Tumor Biol.. 34, 1171\u20131176 (2013).","journal-title":"Tumor Biology"},{"issue":"1516","key":"32477_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4414\/smw.2006.10955","volume":"136","author":"D Goede","year":"2006","unstructured":"Goede, D. & Hauser, R. Increased prevalence of high body mass index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med. Wkly. 136 (1516), 254\u2013258 (2006).","journal-title":"Swiss Med. Wkly."},{"issue":"4","key":"32477_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.mehy.2010.12.017","volume":"76","author":"BC Melnik","year":"2011","unstructured":"Melnik, B. C. Milk signalling in the pathogenesis of type 2 diabetes. Med. Hypotheses. 76 (4), 553\u2013559 (2011).","journal-title":"Med. Hypotheses"},{"issue":"4","key":"32477_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/aje\/kwv326","volume":"184","author":"T Wang","year":"2016","unstructured":"Wang, T. et al. Circulating prolactin and risk of type 2 diabetes: a prospective study. Am. J. Epidemiol. 184 (4), 295\u2013301 (2016).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"32477_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/2305-0500.259168","volume":"8","author":"TJ Al-Maiahy","year":"2019","unstructured":"Al-Maiahy, T. J., Al-Gareeb, A. I. & Al-kuraishy, H. M. Prolactin and risk of preeclampsia: A single institution, cross-sectional study. Asian Pac. J. Reprod. 8 (3), 112\u2013117 (2019).","journal-title":"Asian Pac. J. Reprod."},{"issue":"5","key":"32477_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"Bernard, V., Young, J., Chanson, P. & Binart, N. New insights in prolactin: pathological implications. Nat. Rev. Endocrinol. 11 (5), 265\u2013275 (2015).","journal-title":"Nat. Reviews Endocrinol."},{"issue":"1","key":"32477_CR18","first-page":"56","volume":"158","author":"X Ruiz-Herrera","year":"2017","unstructured":"Ruiz-Herrera, X. et al. Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males. Endocrinology 158 (1), 56\u201368 (2017).","journal-title":"Endocrinology"},{"key":"32477_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00592-013-0493-7","volume":"51","author":"R Wagner","year":"2014","unstructured":"Wagner, R. et al. Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol. 51, 71\u201378 (2014).","journal-title":"Acta Diabetol."},{"issue":"7","key":"32477_CR20","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2337\/dc12-1893","volume":"36","author":"T Wang","year":"2013","unstructured":"Wang, T. et al. Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study. Diabetes Care. 36 (7), 1974\u20131980 (2013).","journal-title":"Diabetes Care"},{"issue":"3","key":"32477_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.bbrc.2018.03.048","volume":"498","author":"S Shao","year":"2018","unstructured":"Shao, S. et al. Ablation of prolactin receptor increases hepatic triglyceride accumulation. Biochem. Biophys. Res. Commun. 498 (3), 693\u2013699 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"32477_CR22","doi-asserted-by":"publisher","first-page":"54607","DOI":"10.12775\/QS.2024.22.54607","volume":"22","author":"K Korta","year":"2024","unstructured":"Korta, K. et al. The role of prolactin levels in metabolic syndrome: a systematic review. Qual. Sport. 22, 54607 (2024).","journal-title":"Qual. Sport"},{"key":"32477_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fphar.2019.00371","volume":"10","author":"C Luo","year":"2019","unstructured":"Luo, C. et al. Effect of Metformin on antipsychotic-induced metabolic dysfunction: the potential role of gut-brain axis. Front. Pharmacol. 10, 371 (2019).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"32477_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2337\/diacare.25.1.107","volume":"25","author":"EW Ter Braak","year":"2002","unstructured":"Ter Braak, E. W., Appelman, A. M., van der Tweel, I., Erkelens, D. W. & van Haeften, T. W. The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia. Diabetes Care 25 (1), 107\u2013112 (2002).","journal-title":"Diabetes Care"},{"key":"32477_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejim.2016.01.015","volume":"30","author":"R Krysiak","year":"2016","unstructured":"Krysiak, R., Kowalcze, K., Szkrobka, W. & Okopien, B. The effect of Metformin on prolactin levels in patients with drug-induced hyperprolactinemia. Eur. J. Intern. Med. 30, 94\u201398 (2016).","journal-title":"Eur. J. Intern. Med."},{"key":"32477_CR26","unstructured":"ABOUHOSA, A., GHUNAIM, L., OUDAH, A. & FARAJ, H. DOKUZEYL\u00dcL N. Hyperprolactinemia and infertility female and male. J. Exp. Clin. Medicine\/Deneysel Ve Klinik Tip Dergisi 42(1). (2025)."},{"issue":"1","key":"32477_CR27","doi-asserted-by":"publisher","first-page":"687259","DOI":"10.1155\/2009\/687259","volume":"2009","author":"M Gill-Sharma","year":"2009","unstructured":"Gill-Sharma, M. Prolactin and male fertility: the long and short feedback regulation. Int. J. Endocrinol. 2009 (1), 687259 (2009).","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"32477_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.6026\/97320630016176","volume":"16","author":"PK Gangwar","year":"2020","unstructured":"Gangwar, P. K. et al. Increased gonadotropins and prolactin are linked to infertility in males. Bioinformation 16 (2), 176 (2020).","journal-title":"Bioinformation"},{"issue":"1","key":"32477_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/biomedicines13010066","volume":"13","author":"J Steininger","year":"2024","unstructured":"Steininger, J. et al. A retrospective study in trans individuals undergoing gender affirming testosterone treatment: can changes in prolactin counteract the negative effects on the lipid profile? Biomedicines 13 (1), 66 (2024).","journal-title":"Biomedicines"},{"issue":"2","key":"32477_CR30","doi-asserted-by":"publisher","first-page":"e0211628","DOI":"10.1371\/journal.pone.0211628","volume":"14","author":"F Wagnew","year":"2019","unstructured":"Wagnew, F. et al. Treatment cure rate and its predictors among children with severe acute malnutrition in Northwest ethiopia: a retrospective record review. PloS One. 14 (2), e0211628 (2019).","journal-title":"PloS One"},{"issue":"3","key":"32477_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13 (3), 221\u2013262 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"32477_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti, K. G. M. M. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 15 (7), 539\u2013553 (1998).","journal-title":"Diabet. Med."},{"issue":"6","key":"32477_CR33","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger, T. et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension 75 (6), 1334\u20131357 (2020).","journal-title":"Hypertension"},{"key":"32477_CR34","unstructured":"FAO. Guidelines for measuring house hold and individual dietary diversity. https:\/\/ngo.csd-i.org\/wp-content\/uploads\/Elective-Courses\/303\/FAO-Guidelines-For-Measuring-Household-And-Individual-Dietary-Diversity.pdf (2008)."},{"issue":"14","key":"32477_CR35","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"\u017d Reiner","year":"2011","unstructured":"Reiner, \u017d. et al. ESC\/EAS guidelines for thed management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Eur. Heart J. 32 (14), 1769\u20131818 (2011).","journal-title":"Eur. Heart J."},{"key":"32477_CR36","unstructured":"Coulter, B. LH IRMA KIT: https:\/\/www.beckmancoulter.com\/download\/phxIFU-IM1381-330202-EN_US"},{"issue":"24","key":"32477_CR37","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull, F. C. et al. World health organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 54 (24), 1451\u20131462 (2020).","journal-title":"Br. J. Sports Med."},{"issue":"6","key":"32477_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-2125.2004.02103.x","volume":"57","author":"RV Carlson","year":"2004","unstructured":"Carlson, R. V., Boyd, K. M. & Webb, D. J. The revision of the declaration of helsinki: past, present and future. Br. J. Clin. Pharmacol. 57 (6), 695\u2013713 (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"32477_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/japtr.JAPTR_65_19","volume":"10","author":"HA Rasheed","year":"2019","unstructured":"Rasheed, H. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Hussien, N. R. & Al-Nami, M. S. Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon. J. Adv. Pharm. Tech. Res. 10 (4), 163\u2013168 (2019).","journal-title":"J. Adv. Pharm. Tech. Res."},{"issue":"3","key":"32477_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/IJCIIS.IJCIIS_40_19","volume":"9","author":"MS Al-Nami","year":"2019","unstructured":"Al-Nami, M. S., Al-Kuraishy, H. M., Al-Gareeb, A. I. & Al-Mamoori, F. Metabolic profile and prolactin serum levels in men with type 2 diabetes mellitus: old-new rubric. Int. J. Crit. Illn. Inj. Sci. 9 (3), 120\u2013126 (2019).","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"32477_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.12.029","volume":"109","author":"FL Vicchi","year":"2016","unstructured":"Vicchi, F. L. et al. Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacol. Res. 109, 74\u201380 (2016).","journal-title":"Pharmacol. Res."},{"issue":"5","key":"32477_CR42","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.dsx.2018.07.007","volume":"13","author":"N Manshaei","year":"2019","unstructured":"Manshaei, N. et al. An investigation of the association between the level of prolactin in serum and type II diabetes. Diabetes Metabol. Syndr.  Clin. Res. Rev.. 13 (5), 3035\u20133041 (2019).","journal-title":"Diabetes Metabolic Syndrome: Clin. Res. Reviews"},{"issue":"4","key":"32477_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","volume":"31","author":"Y Macotela","year":"2020","unstructured":"Macotela, Y., Triebel, J. & Clapp, C. Time for a new perspective on prolactin in metabolism. Trends Endocrinol. Metabol.. 31 (4), 276\u2013286 (2020).","journal-title":"Trends Endocrinol. Metabolism"},{"issue":"1","key":"32477_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6823-13-12","volume":"13","author":"L Balbach","year":"2013","unstructured":"Balbach, L. et al. Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? BMC Endocr. Disord.. 13 (1), 12 (2013).","journal-title":"BMC Endocr. Disorders"},{"issue":"4","key":"32477_CR45","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1210\/en.2008-1003","volume":"150","author":"C Huang","year":"2009","unstructured":"Huang, C., Snider, F. & Cross, J. C. Prolactin receptor is required for normal glucose homeostasis and modulation of \u03b2-cell mass during pregnancy. Endocrinology 150 (4), 1618\u20131626 (2009).","journal-title":"Endocrinology"},{"issue":"6","key":"32477_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/dmrr.1215","volume":"27","author":"S Park","year":"2011","unstructured":"Park, S., Kim, D. S., Daily, J. W. & Kim, S. H. Serum prolactin concentrations determine whether they improve or impair \u03b2-cell function and insulin sensitivity in diabetic rats. Diab.\/Metab. Res. Rev. 27 (6), 564\u2013574 (2011).","journal-title":"Diab.\/Metab. Res. Rev."},{"issue":"4","key":"32477_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000336501","volume":"95","author":"S Park","year":"2012","unstructured":"Park, S., Kang, S., Lee, H-W. & Ko, B. S. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats. Neuroendocrinology 95 (4), 332\u2013343 (2012).","journal-title":"Neuroendocrinology"},{"issue":"2","key":"32477_CR48","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jcem-57-2-334","volume":"57","author":"C CARLSON","year":"1983","unstructured":"CARLSON, C., Wasser, H. L., Levin, S. R. & Wilkins, J. N. Prolactin stimulation by meals is related to protein content. J. Clin. Endocrinol. Metabol.. 57 (2), 334\u2013338 (1983).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"5","key":"32477_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1210\/jcem-52-5-1043","volume":"52","author":"M Quigley","year":"1981","unstructured":"Quigley, M., Ropert, J. & Yen, S. Acute prolactin release triggered by feeding. J. Clin. Endocrinol. Metabol.. 52 (5), 1043\u20131045 (1981).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"32477_CR50","doi-asserted-by":"crossref","unstructured":"Grassa, A. et al. (eds) Quel r\u00f4le jouerait l\u2019hyperprolactin\u00e9mie dans l\u2019\u00e9quilibre glyc\u00e9mique de l\u2019homme diab\u00e9tique de type 2? Annales d\u2019Endocrinologie (Elsevier, 2023).","DOI":"10.1016\/j.ando.2023.07.407"},{"key":"32477_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.urology.2021.03.007","volume":"159","author":"SS Ambulkar","year":"2022","unstructured":"Ambulkar, S. S. et al. Prevalence of hyperprolactinemia and clinically apparent prolactinomas in men undergoing fertility evaluation. Urology 159, 114\u2013119 (2022).","journal-title":"Urology"},{"key":"32477_CR52","doi-asserted-by":"publisher","first-page":"935872","DOI":"10.3389\/fcdhc.2023.935872","volume":"4","author":"H-Y Chien","year":"2023","unstructured":"Chien, H-Y., Chen, S-M. & Li, W-C. Dopamine receptor agonists mechanism of actions on glucose Lowering and their connections with prolactin actions. Front. Clin. Diabetes Healthc. 4, 935872 (2023).","journal-title":"Front. Clin. Diabetes Healthc."},{"key":"32477_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1464-5491.2008.02504.x","volume":"25","author":"S Genuth","year":"2008","unstructured":"Genuth, S. The UKPDS and its global impact. Diabet. Med. 25, 57\u201362 (2008).","journal-title":"Diabet. Med."},{"issue":"6","key":"32477_CR54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"W Knowler","year":"2002","unstructured":"Knowler, W. et al. Diabetes prevention program research group. N Engl. J. Med. 346 (6), 393\u2013403 (2002).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"32477_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s13410-015-0344-x","volume":"35","author":"WA Rabie","year":"2015","unstructured":"Rabie, W. A., El-Said, N. H., Mohammed, A. F. & Sayed, S. G. Role of prolactin as a cardiovascular risk in type 2 diabetes mellitus patients: a case-control study in Egypt. Int. J. Diabetes Devel.  Ctries. 35 (4), 565\u2013569 (2015).","journal-title":"Int. J. Diabetes Developing Ctries."},{"issue":"1","key":"32477_CR56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12902-022-01225-x","volume":"22","author":"A Niknam","year":"2022","unstructured":"Niknam, A. et al. The effects of different physiologic concentrations of prolactin in association with reproductive hormones on the incidence of type 2 diabetes mellitus in men: Tehran lipid and glucose study. BMC Endocr. Disord.. 22 (1), 302 (2022).","journal-title":"BMC Endocr. Disorders"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32477-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:03:32Z","timestamp":1769216612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32477"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32477-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethical clearance committee of Biomedical and laboratory Science of the University of Gondar. Each participant was informed in detail and his\/her consent was obtained before the data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent to publish this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"2570"}}